Home LiteratureArticle Details
PMID: 6988545 Published · ppublish English Journal Article

Rough mutants of Salmonella typhimurium: immunochemical and structural analysis of lipopolysaccharides from rfaH mutants.

Journal of general microbiology ·Vol. 116 ·No. 1 ·1980-01-00 ·Pages 25-32

Lindberg AA, Hellerqvist CG

Abstract

Lipopolysaccharides, extracted by phenol/chloroform/petroleum ether, from two rough mutants of Salmonella typhimurium of class rfaH were studied by passive haemagglutination inhibition and by methylation analysis. The structural and immunochemical analyses showed that (i) formation of the galactose I unit of the core is defective, but the defect is not complete, and (ii) of those core chains which do receive the galactose I residue, many are not continued to form complete core, but instead terminate at intermediate points. This suggests that the rfaH gene, though involved in formation of the galactose I unit, is not the structural gene for the galactosyltransferase which adds this unit. The rfaH product may be a positive regulator for several rfa genes specifying glycosyltransferases, or it may be a protein needed for the efficient action of several such transferases.

MeSH Terms
Chemical Phenomena Chemistry Hemagglutination Inhibition Tests Hexoses/analysis Lipopolysaccharides/immunology Methylation Mutation Salmonella Phages Salmonella typhimurium/analysis,genetics
Chemicals
Hexoses Lipopolysaccharides
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lindberg A A
Hellerqvist C G
Article Info
Journal
Journal of general microbiology
Abbr.
J Gen Microbiol
ISSN
0022-1287
Published
1980-01-00
Pages
25-32
Language
English
Region
England
NLM ID
0375371
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com